newdrugapprovals.org
OSILODROSTAT for Treatment of Cushing’s Syndrome
OSILODROSTAT LCI 699, LCI 699NX Novartis Ag INNOVATOR UNII-5YL4IQ1078, CAS 928134-65-0 Benzonitrile, 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluoro- 4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2…